Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AEA Technology

Latest From AEA Technology

Prosonix Extends Series B Financing, Plans Generic Fluticasone Filing

Prosonix receives an extra $9 million for its Series B round as it changes business strategy from contract research to the development of generic respiratory products, based on a novel particle-engineering technology for inhaled powders.

BioPharmaceutical Europe

Pfizer: Innovation at the Lowest Cost

Pfizer's economic figuring goes something like this: an internally discovered drug, or one licensed for relatively little money at an early stage of development, can nonetheless be considerably less profitable than one in-licensed when it is nearly ready for NDA filing, even if the drug costs a small fortune in cash and quids.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Tech. Transfer Entity
  • Parent & Subsidiaries
  • AEA Technology
  • Senior Management
  • Jill Pain, CFO
    Chris Wright, Managing Dir.
    Marcus Lofting
    Kevin Maynard
    Alan Nichols
  • Contact Info
  • AEA Technology
    Phone: (44) 1925 252512
    Thomson House, Risley Warrington
    , WA3 6AT